Bob Corker actually said...

These capital-intensive firms face unique challenges in raising the significant amounts of money necessary to complete clinical trials and complete development of cutting-edge drugs.

Context

Corker highlights challenges faced by biotech firms in raising capital.

03/05/2012

https://www.congress.gov...

More Bob Corker Quotes

View All Bob Corker Quotes